Clinical trial
Irinotecan Discontinuation and Reintroduction for Advanced Colorectal Cancer
NCT00320320 · Gachon University Gil Medical Center, Other · Terminated
Key facts
| NCT number | NCT00320320 |
|---|---|
| Title | Irinotecan Discontinuation and Reintroduction for Advanced Colorectal Cancer |
| Official title | A Pilot Phase II Trial of Irinotecan Discontinuation and Reintroduction in Patients With Previously Untreated Advanced Colorectal Cancer |
| Lead sponsor | Gachon University Gil Medical Center, Other |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Neoplasms, Metastases |
| Intervention type | Drug |
| Interventions | Irinotecan |
| Enrollment | 72 |
| Start date | Apr 1, 2005 |
| Primary completion | Apr 1, 2007 |
| Completion | Apr 1, 2007 |
| First posted | May 3, 2006 |
| Last update posted | Nov 25, 2008 |
| Countries | South Korea |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: